{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:43:31Z","timestamp":1759797811589,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202240152"],"award-info":[{"award-number":["202240152"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23Y11907400"],"award-info":[{"award-number":["23Y11907400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01949-x","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:54:19Z","timestamp":1759758859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced diagnostic performance for subcentimeter hepatocellular carcinoma using a novel criterion integrating serum AFP levels and gadolinium-based contrast-enhanced MRI features"],"prefix":"10.1186","volume":"25","author":[{"given":"Xuying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4015-6018","authenticated-orcid":false,"given":"Haoran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinde","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"1949_CR1","unstructured":"Robin Kate K, Tim FG. Hepatocellular carcinoma \u2014 origins and outcomes. N Engl J Med. 2021."},{"key":"1949_CR2","doi-asserted-by":"crossref","unstructured":"Reddy KR, Dale M, Tracey M, Neehar DP, Lewis RR, Myron S, Mindie HN, Alex SB, Stephanie P-L, Runlong T, et al. Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study. Gastroenterology. 2023.","DOI":"10.1053\/j.gastro.2023.06.027"},{"key":"1949_CR3","doi-asserted-by":"crossref","unstructured":"Ince MN, Jack RW. The increasing incidence of hepatocellular carcinoma. N Engl J Med. 1999.","DOI":"10.1056\/NEJM199903113401009"},{"key":"1949_CR4","unstructured":"Paulo SP, Patricia DJ, Heidy NM, Hannah MC, Tulay KS, Tim B, Robert JW, Erin K, Katherine AM. Incidence of etiology-specific hepatocellular carcinoma: diverging trends and significant heterogeneity by race and ethnicity. Clin Gastroenterol Hepatol. 2023."},{"key":"1949_CR5","doi-asserted-by":"crossref","unstructured":"Huang P, Ni X, Zhou C, Shi Z, Wu F, Xiao Y, Yang C, Zeng M. Subcentimeter nodules with diagnostic hallmarks of hepatocellular carcinoma: comparison of pathological features and survival outcomes with nodules measuring 1\u20132\u00a0cm. J Hepatocellular Carcinoma. 2023;169\u201380.","DOI":"10.2147\/JHC.S401027"},{"issue":"46","key":"1949_CR6","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.3748\/wjg.v24.i46.5215","volume":"24","author":"MW Lee","year":"2018","unstructured":"Lee MW, Lim HK. Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: current status and future. World J Gastroenterol. 2018;24(46):5215.","journal-title":"World J Gastroenterol"},{"key":"1949_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-020-01996-4","volume":"18","author":"X-Q Li","year":"2020","unstructured":"Li X-Q, Wang X, Zhao D-W, Sun J, Liu J-J, Lin D-D, Yang G, Liu H, Xia Z-Y, Jia C-Y. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma. World J Surg Oncol. 2020;18:1\u20138.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"1949_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jhep.2019.12.011","volume":"72","author":"A Paisant","year":"2020","unstructured":"Paisant A, Vilgrain V, Riou J, Oberti F, Sutter O, Laurent V, Rodes A, Guiu B, Cassinotto C, Trillaud H. Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs. J Hepatol. 2020;72(5):937\u201345.","journal-title":"J Hepatol"},{"key":"1949_CR9","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s00261-021-03076-x","volume":"46","author":"A Aslam","year":"2021","unstructured":"Aslam A, Kamath A, Spieler B, Maschiocchi M, Sabottke CF, Chernyak V, Lewis SC. Assessing locoregional treatment response to hepatocellular carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents. Abdom Radiol. 2021;46:3565\u201378.","journal-title":"Abdom Radiol"},{"issue":"6","key":"1949_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/2210298103666230410104223","volume":"3","author":"P Huang","year":"2023","unstructured":"Huang P, Xiao Y, Zhou C, Wu F, Yang C, Zeng M. Current status of imaging diagnosis and treatment of subcentimeter hepatocellular carcinoma. Curr Chin Sci. 2023;3(6):408\u201319.","journal-title":"Curr Chin Sci"},{"key":"1949_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng A-L, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han K-H, Chawla YK, Shiina S. Asia\u2013Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hep Intl. 2017;11:317\u201370.","journal-title":"Hep Intl"},{"issue":"3","key":"1949_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000327577","volume":"29","author":"M Kudo","year":"2011","unstructured":"Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M, Hepatology HEPJS. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version. Dig Dis. 2011;29(3):339\u201364.","journal-title":"Dig Dis"},{"issue":"2","key":"1949_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68(2):723\u201350.","journal-title":"Hepatology"},{"issue":"1","key":"1949_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"P Galle","year":"2018","unstructured":"Galle P, Forner A, Llovet J, Mazzaferro V, Piscaglia F, Raoul J. European association for the study of the liver electronic address eee, European association for the study of the L: EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"12","key":"1949_CR15","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/liv.14223","volume":"39","author":"PR Galle","year":"2019","unstructured":"Galle PR, Foerster F, Kudo M, Chan SL, Llovet JM, Qin S, Schelman WR, Chintharlapalli S, Abada PB, Sherman M. Biology and significance of alpha-fetoprotein in hepatocellular carcinoma. Liver Int. 2019;39(12):2214\u201329.","journal-title":"Liver Int"},{"issue":"6","key":"1949_CR16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cells9061370","volume":"9","author":"F Pi\u00f1ero","year":"2020","unstructured":"Pi\u00f1ero F, Dirchwolf M, Pess\u00f4a MG. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells. 2020;9(6):1370.","journal-title":"Cells"},{"issue":"4","key":"1949_CR17","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00330-022-09282-5","volume":"33","author":"P Huang","year":"2023","unstructured":"Huang P, Zhou C, Wu F, Xiao Y, Qian X, Wang Y, Yang C, Zeng M. An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on Gadoxetic acid\u2013enhanced MRI. Eur Radiol. 2023;33(4):2735\u201345.","journal-title":"Eur Radiol"},{"issue":"2","key":"1949_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jmri.27824","volume":"55","author":"H Jiang","year":"2022","unstructured":"Jiang H, Song B, Qin Y, Wei Y, Konanur M, Wu Y, Zaki IH, McInnes MD, Lafata KJ, Bashir MR. Data-driven modification of the LI\u2010RADS major feature system on gadoxetate disodium\u2010enhanced MRI: toward better sensitivity and simplicity. J Magn Reson Imaging. 2022;55(2):493\u2013506.","journal-title":"J Magn Reson Imaging"},{"key":"1949_CR19","doi-asserted-by":"crossref","unstructured":"Dai H, Xiao Y, Fu C, Grimm R, von Busch H, Stieltjes B, Choi MH, Xu Z, Chabin G, Yang C. Deep learning\u2013based approach for identifying and measuring focal liver lesions on contrast-enhanced MRI. J Magn Reson Imaging. 2024.","DOI":"10.1002\/jmri.29404"},{"key":"1949_CR20","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system; 2010."},{"key":"1949_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS. The 2017 world health organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 2017;134:521\u201335.","journal-title":"Acta Neuropathol"},{"key":"1949_CR22","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s00261-018-1744-4","volume":"43","author":"KM Elsayes","year":"2018","unstructured":"Elsayes KM, Kielar AZ, Elmohr MM, Chernyak V, Masch WR, Furlan A, Marks RM, Cruite I, Fowler KJ, Tang A. White paper of the society of abdominal radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol. 2018;43:2625\u201342.","journal-title":"Abdom Radiol"},{"issue":"1","key":"1949_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3748\/wjg.v22.i1.262","volume":"22","author":"P-P Song","year":"2016","unstructured":"Song P-P, Xia J-F, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol. 2016;22(1):262.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1949_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3350\/cmh.2019.0010","volume":"25","author":"JD Yang","year":"2019","unstructured":"Yang JD. Detect or not to detect very early stage hepatocellular carcinoma? The Western perspective. Clin Mol Hepatol. 2019;25(4):335.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"1949_CR25","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922\u201365.","journal-title":"Hepatology"},{"key":"1949_CR26","unstructured":"Tae Hyung K, So Yeon K, An T, Jeong Min L. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol. 2019."},{"key":"1949_CR27","unstructured":"Sunyoung L, Seung-seob K, Dong Ryul C, Hyerim K, Do Young K. Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging. Clin Mol Hepatol. 2020."},{"issue":"4","key":"1949_CR28","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00330-023-10214-0","volume":"34","author":"P Huang","year":"2024","unstructured":"Huang P, Wu F, Hou K, Zhou C, Xiao Y, Wang C, Miao G, Yang C, Zeng M. Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on Gadoxetic acid\u2013enhanced MRI. Eur Radiol. 2024;34(4):2271\u201382.","journal-title":"Eur Radiol"},{"key":"1949_CR29","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00330-015-3686-3","volume":"25","author":"I Joo","year":"2015","unstructured":"Joo I, Lee JM, Lee DH, Jeon JH, Han JK, Choi BI. Noninvasive diagnosis of hepatocellular carcinoma on Gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? Eur Radiol. 2015;25:2859\u201368.","journal-title":"Eur Radiol"},{"issue":"43","key":"1949_CR30","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.3748\/wjg.v18.i43.6269","volume":"18","author":"A Tateyama","year":"2012","unstructured":"Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K, Nakajo M. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography. World J Gastroenterology: WJG. 2012;18(43):6269.","journal-title":"World J Gastroenterology: WJG"},{"key":"1949_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11901-018-0441-7","volume":"17","author":"KJ Fowler","year":"2018","unstructured":"Fowler KJ, Hecht E, Kielar AZ, Singal AG, Sirlin CB. LI-RADS v2018: a primer and update for clinicians. Curr Hepatol Rep. 2018;17:425\u201333.","journal-title":"Curr Hepatol Rep"},{"issue":"1","key":"1949_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pro6.70005","volume":"9","author":"J Xu","year":"2025","unstructured":"Xu J, Zhang L, Liu Q, Zhu J. Preoperative multiparameter MRI-based prediction of Ki\u201067 expression in primary central nervous system lymphoma. Precision Radiation Oncol. 2025;9(1):23\u201334.","journal-title":"Precision Radiation Oncol"},{"issue":"2","key":"1949_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0168-8278(00)80369-4","volume":"33","author":"R Kutami","year":"2000","unstructured":"Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000;33(2):282\u20139.","journal-title":"J Hepatol"},{"key":"1949_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.25259\/JCIS_221_2020","volume":"11","author":"SBRE Matondang","year":"2021","unstructured":"Matondang SBRE, Karismaputri KS, Suharlim E, Yonathan IWM. Hepatocellular carcinoma with macroscopic fat metamorphosis: a case series. J Clin Imaging Sci. 2021;11:36.","journal-title":"J Clin Imaging Sci"},{"issue":"8","key":"1949_CR35","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/RLI.0000000000000562","volume":"54","author":"J Son","year":"2019","unstructured":"Son J, Hwang SH, Park S, Han K, Chung YE, Choi J-y, Kim M-j, Park M-S. Imaging features of hepatocellular carcinoma: quantitative and qualitative comparison between MRI-Enhanced with Gd-EOB-DTPA and Gd-DTPA. Invest Radiol. 2019;54(8):494\u20139.","journal-title":"Invest Radiol"},{"issue":"3","key":"1949_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/jmri.22291","volume":"32","author":"S Lee","year":"2010","unstructured":"Lee S, Kim SH, Park CK, Kim Y, Lee WJ, Lim HK. Comparison between areas with Gd-EOB\u2010DTPA uptake and without in hepatocellular carcinomas on Gd\u2010EOB\u2010DTPA\u2010enhanced hepatobiliary\u2010phase MR imaging: pathological correlation. J Magn Reson Imaging. 2010;32(3):719\u201325.","journal-title":"J Magn Reson Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01949-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:54:21Z","timestamp":1759758861000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01949-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01949-x","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Review Committee of Zhongshan Hospital, Fudan University (Approval No.: B2021-113R) and was conducted in accordance with the ethical principles of the Declaration of Helsinki. The requirement for informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"During the preparation of this work, we used Tongyi Qwen 2.5 to refine the language of the article. After utilizing this service, we reviewed and edited the content as necessary and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"We confirm that all authors have read the final version of this manuscript, agree with its content, and consent to its submission for publication. All authors take full responsibility for the work presented herein.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}